These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2192750)
1. Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Mori S; Jee WS; Li XJ; Chan S; Kimmel DB Bone; 1990; 11(2):103-13. PubMed ID: 2192750 [TBL] [Abstract][Full Text] [Related]
2. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats. Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats. Ke HZ; Li M; Jee WS Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347 [TBL] [Abstract][Full Text] [Related]
5. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats. Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. Jee WS; Mori S; Li XJ; Chan S Bone; 1990; 11(4):253-66. PubMed ID: 2242291 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy. Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919 [TBL] [Abstract][Full Text] [Related]
8. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats. Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930 [TBL] [Abstract][Full Text] [Related]
9. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2. Mori S; Jee WS; Li XJ Calcif Tissue Int; 1992 Jan; 50(1):80-7. PubMed ID: 1739875 [TBL] [Abstract][Full Text] [Related]
10. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat. Ito H; Ke HZ; Jee WS; Sakou T Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats. Ma YF; Ke HZ; Jee WS Bone; 1994; 15(2):137-46. PubMed ID: 8086230 [TBL] [Abstract][Full Text] [Related]
12. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat. Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795 [TBL] [Abstract][Full Text] [Related]
13. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats. Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081 [TBL] [Abstract][Full Text] [Related]
14. Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats. Mo A; Yao W; Li C; Tian X; Su M; Ling Y; Zhang Q; Setterberg RB; Jee WS Bone; 2002 Sep; 31(3):402-6. PubMed ID: 12231413 [TBL] [Abstract][Full Text] [Related]
15. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377 [TBL] [Abstract][Full Text] [Related]
16. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats. Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244 [TBL] [Abstract][Full Text] [Related]
17. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats. Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383 [TBL] [Abstract][Full Text] [Related]
18. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats. Liang HH; Ma YF; Jee WS; Pan Z; Setterberg RB; McOsker JE; Li XJ Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936 [TBL] [Abstract][Full Text] [Related]
19. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats. Zhou H; Ma YF; Yao W; Cui L; Setterberg R; Liang CT; Jee WS Calcif Tissue Int; 2001 Mar; 68(3):179-84. PubMed ID: 11351502 [TBL] [Abstract][Full Text] [Related]
20. Effects of daily administration of prostaglandin E2 and its withdrawal on the lumbar vertebral bodies in male rats. Ke HZ; Jee WS Anat Rec; 1992 Oct; 234(2):172-82. PubMed ID: 1416104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]